Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
TBPH compared with CAN: revenue, margins and what each company keeps, and the suppliers and customers both name
TBPH
Theravance Biopharma, Inc.
Change
Mkt cap
Revenue
Revenue
CAN
Canaan Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
TBPH
Theravance Biopharma, Inc.
vs
CAN
Canaan Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
TBPH
Theravance Biopharma, Inc.
Change
17.03
▲
+0.02%
· post 17.04
Mkt cap
$884.2M
Revenue
$21M
Q2 FY26
Revenue
$107M
FY25
CAN
Canaan Inc.
Change
0.20
▼
−12.00%
· post 0.20
Closed
Oct 30 '26
Mkt cap
$143.6M
Revenue
—
Revenue
—
vs
Compare
Closed
Oct 30 '26
TBPH
Theravance Biopharma, Inc.
vs
CAN
Canaan Inc.
17.03
▲
+0.02%
post 17.04
Price
0.20
▼
−12.00%
post 0.20
$884.2M
Mkt cap
$143.6M
Q2 FY26
$21M
Revenue
—
FY25
$107M
Revenue
—
Change
Change
TBPH
17.03
▲
+0.02%
vs
CAN
0.20
▼
−12.00%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
TBPH, solid
CAN, dashed
Supply-chain overlap
Revenue flow
TBPH: latest quarter is a loss; flow not drawable. CAN: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only TBPH
6
VTRS
Viatris
supplier
LAZ
Lazard
supplier
GSK
GSK
customer
RPRX
Royalty Pharma Investments
customer
2 more · TBPH chain
›
Shared
0
No disclosed counterparties: CAN.
Only CAN
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR